Eric Burak

Eric Burak has a extensive background in pharmaceutical development and research spanning over several decades. Eric has held various leadership roles in companies such as Fusion Pharmaceuticals, Rib-X Pharmaceuticals, and Guilford Pharmaceuticals, focusing on areas such as drug metabolism, pharmacokinetics, and clinical development. Burak's expertise includes overseeing research and development activities, managing budgets and projects, and collaborating with external partners to meet corporate goals. Eric holds a Ph.D. in Analytical Chemistry from Temple University and a B.S. in Chemistry from Drexel University.